•
Dec 31, 2021

Selecta Biosciences Q4 2021 Earnings Report

Total Revenue
$29.9M
Previous year: $12M
+150.5%
EPS
$0.03
Previous year: -$0.14
-121.4%
Gross Profit
$29.9M
Previous year: $12M
+150.5%
Cash and Equivalents
$114M
Previous year: $139M
-17.8%
Free Cash Flow
-$31.7M
Previous year: -$7.44M
+326.6%
Total Assets
$160M
Previous year: $165M
-3.4%

Selecta Biosciences

Selecta Biosciences